In the last trading session, 2.5 million Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.93. With the company’s per share price at $4.67 changed hands at -$0.1 or -2.10% during last session, the market valuation stood at $962.72M. BCRX’s last price was a discount, traded about -94.0% off its 52-week high of $9.06. The share price had its 52-week low at $4.45, which suggests the last value was 4.71% up since then. When we look at Biocryst Pharmaceuticals Inc.’s average trading volume, we note the 3-month average coming to 3.09 million.

Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) trade information

Instantly BCRX was in red as seen at the end of in last trading. With action 1.30%, the performance over the past five days has been green. The drop to weekly highs of 5.16 subtracted -2.10% to the stock’s daily price. The company’s shares are showing year-to-date downside of -22.04%, with the 5-day performance at 1.30% in the green. However, in the 30-day time frame, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) is -4.50% down.

Biocryst Pharmaceuticals Inc. (BCRX) estimates and forecasts

Data shows that the Biocryst Pharmaceuticals Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -21.91% over the past 6 months, a 32.00% in annual growth rate that is considerably higher than the industry average of 9.40%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -3.73%. The 2024 estimates are for Biocryst Pharmaceuticals Inc. earnings to increase by 43.24%, but the outlook for the next 5-year period is at 44.80% per year.

BCRX Dividends

Biocryst Pharmaceuticals Inc. is expected to release its next quarterly earnings report in May.